SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats
Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK
Loading...



Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand,
Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody
First UNICEF procurement contract strengthens SK bioscience's presence in global public procurement markets
Continue reading uninterrupted with a subscription